The use of toxicodynamics in risk assessment

Toxicology Letters

Volumn 120, Issue 1-3, 2001, Pages 131-141

  Heinrich Hirsch, Barbara ^a   Madle, Stephan ^a   Oberemm, Axel ^a   Gundert Remy, Ursula ^a  

^a Federal Institute for Health Protection of Consumers and Veterinary Medicine (BgVV)   (Germany)

Author keywords

Endpoints; Risk assessment; Toxicodynamics

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; XENOBIOTIC AGENT;

CONFERENCE PAPER; DOSE RESPONSE; DRUG ACTIVITY; DRUG SCREENING; EXPOSURE; FERTILITY; GENOTOXICITY; HORMONE RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECEPTOR BINDING; REPRODUCTION; RISK ASSESSMENT;

ANIMALS; DNA ADDUCTS; DNA DAMAGE; ENDOCRINE GLANDS; HUMANS; PHENOLS; RISK ASSESSMENT;

EID: 0035977870     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(01)00291-0     Document Type: Article

References (50)

1. New insights into cyclosporine A nephrotoxicity by proteome analysis
2. Two-dimensional gel analysis of protein expression in ovarian tumors shows a low degree of intratumoral heterogeneity
3. Cancer proteomics: From identification of novel markers to creation of arteficial learning models for tumor classification
4. Frequencies of HPRT mutant lymphocytes in smokers, non-smokers, and former smokers
5. Proteome and proteomics: New technologies, new concepts, and new words
6. A comparison of selected mRNA and protein abundances in human liver
7. Effects of oltipraz and related chemoprevention compounds on gene expression in rat liver
8. Comet assay responses as indicators of carcinogen exposure
9. Uterotrophic activity of Bisphenol A in the immature rat
10. Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz(a)anthracene-induced lymphomas
11. Normal reproductive organ development in Wistar rats exposed to bisphenol A in drinking water
12. Normal reproductive organ development in CF-1 mice following prenatal exposure to bisphenol A
13. Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progression of human bladder transitional cell carcinomas
14. The application of physiologically based pharmacokinetic modelling in human health risk assessment of hazardous substances
15. Developmental effects of endocrine disrupting chemical in wildlife and humans
16. Profound effects of the weak environmental estrogen-like chemical Bisphenol A on the growth of the mammary gland of noble rats
17. Biologically based pharmacodynamic models. Tools for toxicological research and risk assessment
18. Monitoring of human exposure to carcinogens through DNA and protein adduct determination
19. Tumours and DNA adducts in mice exposed to benz(a)pyrene and coar tars: Implications for risk assessment
20. Bisphenol A interacts with the estrogen receptor α in a distinct manner from estradiol
21. Molecular biomarkers for aflatoxins and their application to human cancer prevention
22. Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic Study Group on the Health Risk of Chromosome Damage
23. Chromosomal aberrations in lymphocytes predict human cancer: A report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH)
24. Conceptual framework for evaluating a mode of action for chemical cancerogenesis
25. Protein structure analysis of today: Proteomics in functional genomics
26. Uncertainty, variability, and sensitivity analysis in physiological pharmacokinetic models
27. Bisphenol A: An estrogenic substance is released from polycarbonate flasks during autoclaving
28. Initiated rat hepatocytes in primary culture: A novel tool to study alterations in growth control during the first stage of carcinogenesis
29. The application of physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) modelling to understanding the mechanism of action of hazardous substances
30. Modelling of residual variability in toxicokinetic studies with sparse sampling: The case of tetrahydronaphthalene
31. Extrapolating the future: Research trends in modelling
32. Relative potency of xenobiotic estrogens in an acute in vivo mammalian assay
33. A break point map of recurrent chromosomal rearrangements in human neoplasia
34. A follow up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China
35. Significance of aneuploidy
36. Application of DNA arrays to toxicology
37. Structural identifiability of PBPK models: Practical consequences for modelling strategies and study designs
38. Assessment of exposure to butadiene in the process industry
39. The E-SCREEN assay as a tool to identify estrogens: An update on estrogenic environmental pollutants
40. The Comet assay (single-cell gel test). A sensitive genotoxicity test for the detection of DNA damage and repair
41. The environmental estrogen Bisphenol A stimulates prolactin release in vitro and in vivo
42. The xenoestrogen Bisphenol A induces growth, differentiation, and c-fos gene expression in the female reproductive tract
43. Biological effect monitoring in industrial workers following incidental exposure to high concentrations of ethylene oxide
44. Haemoglobin adducts for in vivo dose monitoring and cancer risk estimation
45. Use of biomarkers-new frontiers in occupational toxicology and epidemiology
46. Two-dimensional electrophoretic analysis of compartment-specific hepatic protein charge modification induced by thioacetamide exposure in rats
47. Nongenotoxic carcinogens: Development of detection methods based on mechanisms: A European project
48. Further characterization of a rat hepatoma-derived aldose-reductase-like protein - Organ distribution and modulation in vitro
49. Benzene increases aneuploidy in the lymphocytes of exposed workers: A comparison of data obtained by fluorescence in situ hybridization in interphase and metaphase cells